Search - tctmd.com

Displaying 221 - 240 of 294

Sort: Relevancy | Date

News Daily News

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Caitlin E. Cox

May 26, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Industry News

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

April 07, 2016

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

News Conference News ISET 2016

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Michael O'Riordan

February 10, 2016

News Industry News

QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon

January 06, 2016

News Daily News

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Caitlin E. Cox

November 26, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

News Industry News

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

October 14, 2015

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

Presentation TCT 2015

Cre8: Design, Current Status, and Future Directions

Presenter: Marie-Claude Morice, Leif Thuesen, Didier Carrié

October 12, 2015

Presentation TCT 2015

Drug-Filled Stent: Concept, Preclinical Studies, and Early Clinical Observations

Presenter: Marie-Claude Morice, Leif Thuesen, Stephen G. Worthley

October 12, 2015

Presentation TCT 2015

BioFreedom II: LEADERS FREE Rationale and Late-Breaking Clinical Trial Preview

Presenter: Marie-Claude Morice, Leif Thuesen, Philip M. Urban

October 12, 2015

Presentation TCT 2015

BioFreedom I: Angiographic Results and Late Clinical Outcomes of the FIM Trial

Presenter: Marie-Claude Morice, Leif Thuesen, Christian M. Spaulding

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

News Industry News

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

October 07, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

Advertisement

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

Cre8: Design, Current Status, and Future Directions

Drug-Filled Stent: Concept, Preclinical Studies, and Early Clinical Observations

BioFreedom II: LEADERS FREE Rationale and Late-Breaking Clinical Trial Preview

BioFreedom I: Angiographic Results and Late Clinical Outcomes of the FIM Trial

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content